Filing Details
- Accession Number:
- 0001179110-20-002186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-25 08:38:19
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-25 08:38:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 855654 | Immunogen Inc. | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586965 | J Mark Enyedy | 24 Concord Square Boston MA 02118 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-24 | 55,222 | $4.99 | 433,776 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Weighted average price of shares sold.
- The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.
Billionaire Hedge Funds
